{
    "Trade/Device Name(s)": [
        "Assure 4 Blood Glucose Monitoring System"
    ],
    "Submitter Information": "Apex Biotechnology Corp.",
    "510(k) Number": "K070088",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CGA",
        "NBW"
    ],
    "Summary Letter Date": "February 6, 2007",
    "Summary Letter Received Date": "February 12, 2007",
    "Submission Date": "January 8, 2007",
    "Regulation Number(s)": [
        "21CFR862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Assure 4 Blood Glucose Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Biosensor (glucose oxidase electrochemical detection)"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Analyzer",
        "Test Strip",
        "Control Solution",
        "Code Chip"
    ],
    "Document Summary": "FDA 510(k) summary for Assure 4 Blood Glucose Monitoring System for quantitative measurement of glucose in capillary whole blood",
    "Indications for Use Summary": "Quantitative measurement of glucose in fresh capillary whole blood for home use by persons with diabetes or in clinical settings by healthcare professionals, as an aid to monitor diabetes control",
    "fda_folder": "Clinical Chemistry"
}